Project Grant R01CA310971
Award Date 7/1/26
Completion Date 6/30/31
Dollars Obligated $586K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- Federal Project Grant Award Summary The University of Wisconsin–Madison received a $508,651 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), awarded June 2, 2026, with a completion date of May 31, 2031. This research initiative will deliver fundamental cancer biology research focused on understanding and therapeutically exploiting the role of the neuropeptide receptor PAC1 (pituitary adenylate cyclase-activating polypeptide...
- Federal Project Grant Summary The National Cancer Institute (NCI) awarded a $694,133 Project Grant to Weill Medical College of Cornell University on May 14, 2026, under the Cancer Biology Research program (CFDA 93.396). This five-year award, with an ultimate completion date of April 30, 2031, funds fundamental research investigating how axonal signaling from the sympathetic nervous system controls melanoma tumor progression and resistance to therapy. The project focuses on defining cell types...
- Federal Grant Award Summary The National Cancer Institute awarded The University of Texas MD Anderson Cancer Center a $645,865 Project Grant under the Cancer Biology Research program (CFDA 93.396) beginning July 1, 2026, and concluding June 30, 2031. This five-year research initiative focuses on understanding and disrupting the neuroimmune feedback mechanisms that drive immunotherapy resistance in cutaneous squamous cell carcinoma (CSCC) with perineural invasion (PNI). The research will...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded $410,545 to The Research Foundation For The State University of New York under the Cancer Treatment Research program (CFDA 93.395) for a Project Grant effective May 1, 2026 through April 30, 2028. The award supports research assessing the role of efflux transport mechanisms, pharmacokinetics, and systems pharmacology in monomethyl auristatin E (MMAE)-induced neurotoxicity associated with antibody-drug conjugate (ADC)...
- Federal Grant Award Summary The National Cancer Institute's Cancer Biology Research program (CFDA 93.396) awarded a $661,721 Project Grant to the University of California, San Diego, effective April 1, 2026, through March 31, 2031. This award supports systematic functional mapping and interrogation of oncogenic intrinsically disordered regions (IDRs) in cancer driver proteins. The research will utilize high-throughput functional screening technologies to perform domain and residue-level...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $2.58 million Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded August 11, 2025, and extending through July 31, 2030. This multi-institutional research program investigates the molecular drivers and therapeutic susceptibilities in lineage state transitions of metastatic castrate-resistant prostate cancer (MCRPC). The project addresses critical...
- Federal Project Grant Award Summary The University of Wisconsin-Madison received a $630,171 Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), effective August 12, 2025, with a completion date of July 31, 2030. The award supports the development of targeted radiopharmaceutical therapies (RPTs) for triple-negative breast cancer (TNBC), an aggressive breast cancer subtype that lacks expression of estrogen receptor, progesterone...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. a Project Grant of $433,256 under the Cancer Treatment Research program (CFDA 93.395) for the period of September 1, 2025 through August 31, 2027. This award supports exploratory research into the role of antisense ribonucleic acids (asRNAs) in melanoma development and transformation. The project will deliver scientific research and analysis focused on...
- Federal Grant Award Summary New York University School of Medicine received a $695,852 Project Grant from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) awarded May 1, 2026, with completion scheduled for April 30, 2031. The research investigates T cell circuits within the lymphatic system during melanoma progression, specifically examining tumor-draining lymph nodes (TDLNs) as critical hubs for anti-tumor immune surveillance. The project focuses on...
- Federal Project Grant Award Summary The University of Wisconsin–Madison received a $216,013 Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) effective September 1, 2025, through August 31, 2027. This research project investigates the mechanisms by which Kaposi's sarcoma-associated herpesvirus (KSHV) hijacks cellular caspase enzymes to suppress interferon responses and develop targeted therapeutic strategies to block viral...